Back

rAAV-miniBEND: A targeted vector for brain endothelial cell gene delivery and cerebrovascular malformation modeling

Li, J.-L.; Bi, Z.; Chen, X.-j.; Ming, T.; Qiu, B.; Li, F.; Feng, Z.; Ai, D.; Zhang, T.; Wang, J.; Lin, S.; Lu, Y.; Wang, Z.; Huang, J.; Zhao, F.; Zhao, H.; Wang, Y.; Sun, W.; Ge, W.-p.

2025-06-15 neuroscience
10.1101/2025.06.10.658979 bioRxiv
Show abstract

Defects in brain endothelial cells (brainECs) can cause severe cerebrovascular malformations, including arteriovenous malformation (AVM) and cerebral cavernous malformation (CCM). The lack of appropriate tools for cerebrovascular disease modeling and local genetic manipulation of the brain vasculature hinders research on cerebrovascular malformations. Here we develop a recombinant adeno-associated virus (rAAV) tool miniBEND (rAAV-based mini-system for brain endothelial cells, rAAV-miniBEND), which combines a minimal promoter and an optimized cis-acting element (cis-element) isolated from the mouse gene Tek. This system achieves gene expression specifically in mouse and rat brainECs. Using rAAV-miniBEND, we achieve high-efficiency and high-specificity gene expression in brainECs through intracranial injection at various developmental stages and through intravenous administration at all postnatal stages in mice. Furthermore, we use rAAV-miniBEND to model sporadic CCMs mediated by MAP3K3I441M and AVMs mediated by BrafV600E. We demonstrate that somatic expression of BrafV600E in brainECs induces an AVM phenotype, and that brainEC proliferation are important for AVM development. Thus, our rAAV-miniBEND system provides a valuable and widely applicable tool for cerebrovascular disease modeling and local or global brainEC gene delivery.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Fluids and Barriers of the CNS
21 papers in training set
Top 0.1%
14.7%
2
PLOS ONE
4510 papers in training set
Top 21%
8.6%
3
Molecular Therapy
71 papers in training set
Top 0.2%
8.6%
4
Scientific Reports
3102 papers in training set
Top 13%
7.0%
5
Cell Reports Methods
141 papers in training set
Top 0.5%
4.4%
6
eLife
5422 papers in training set
Top 24%
3.8%
7
Molecular Therapy Nucleic Acids
32 papers in training set
Top 0.2%
3.7%
50% of probability mass above
8
Theranostics
33 papers in training set
Top 0.3%
3.1%
9
Nature Communications
4913 papers in training set
Top 43%
3.0%
10
iScience
1063 papers in training set
Top 12%
1.8%
11
Frontiers in Bioengineering and Biotechnology
88 papers in training set
Top 1%
1.7%
12
Small Methods
26 papers in training set
Top 0.3%
1.7%
13
EMBO Molecular Medicine
85 papers in training set
Top 2%
1.7%
14
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 5%
1.5%
15
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 1%
1.5%
16
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.3%
1.4%
17
Advanced Science
249 papers in training set
Top 13%
1.4%
18
Science Bulletin
22 papers in training set
Top 0.5%
1.3%
19
Cell Reports
1338 papers in training set
Top 30%
0.9%
20
Nucleic Acids Research
1128 papers in training set
Top 16%
0.8%
21
eneuro
389 papers in training set
Top 8%
0.8%
22
Journal of Neuroscience Methods
106 papers in training set
Top 2%
0.8%
23
Molecular Therapy Methods & Clinical Development
13 papers in training set
Top 0.1%
0.8%
24
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.8%
25
Experimental Neurology
57 papers in training set
Top 1%
0.7%
26
Angiogenesis
15 papers in training set
Top 0.3%
0.7%
27
Journal of Controlled Release
39 papers in training set
Top 1%
0.7%
28
Protein & Cell
25 papers in training set
Top 3%
0.5%
29
Frontiers in Neuroscience
223 papers in training set
Top 9%
0.5%
30
Neurophotonics
37 papers in training set
Top 0.8%
0.5%